ProShares Ultra Nasdaq Biotechnology (BIB) Leveraged/Inverse
Holdings data is not available for this fund yet.
BIB Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Performance as of Oct. 2, 2026
| Period | Price return | Total return |
|---|---|---|
| 1M | ▼ -9.84% | ▼ -9.78% |
| 3M | ▲ +2.77% | ▲ +2.84% |
| 6M | ▲ +34.28% | ▲ +34.37% |
| YTD | ▲ +37.63% | ▲ +37.74% |
| 1Y | ▲ +73.21% | ▲ +73.64% |
| 3Y | ▲ +135.47% | ▲ +142.03% |
| 5Y | ▲ +20.16% | ▲ +23.54% |
| Max | ▲ +1362.31% | ▲ +1406.10% |
Total return assumes dividends are reinvested. Returns are not benchmarked against an index. * Sharpe ratio is computed with a 0% risk-free rate.
Fund flows (SEC-reported)
Based on the fund's own SEC Form N-PORT monthly flow disclosures (Item C.9 "Flow Information") — sales minus redemptions, reinvested distributions excluded. This is a different, independent metric from the "Net flows" estimate above (which is derived from daily shares-outstanding changes). SEC N-PORT filing lag is up to ~60 days; the most recent month/quarter may not yet be fully reflected.
Full composition 267 holdings
| Name | CUSIP | Value | % | Balance | Category | Country |
|---|---|---|---|---|---|---|
| Arcturus Therapeutics Holdings, Inc. | 03969T109 | $8K | 0.01 | 1,052 | EC | US |
| Orchestra BioMed Holdings, Inc. | 68572M106 | $8K | 0.01 | 2,089 | EC | US |
| Caribou Biosciences, Inc. | 142038108 | $8K | 0.01 | 3,454 | EC | US |
| Bicycle Therapeutics plc | 088786108 | $8K | 0.01 | 1,711 | EC | GB |
| NovaBridge Biosciences | 44975P103 | $8K | 0.01 | 4,151 | EC | KY |
| Lifecore Biomedical, Inc. | 514766104 | $7K | 0.01 | 1,387 | EC | US |
| Tenaya Therapeutics, Inc. | 87990A106 | $7K | 0.01 | 8,012 | EC | US |
| Jyong Biotech Ltd. | · | $6K | 0.01 | 2,743 | EC | KY |
| Black Diamond Therapeutics, Inc. | 09203E105 | $5K | 0.01 | 2,105 | EC | US |
| Pyxis Oncology, Inc. | 747324101 | $4K | 0.01 | 2,303 | EC | US |
| PepGen, Inc. | 713317105 | $4K | 0.01 | 2,541 | EC | US |
| Rani Therapeutics Holdings, Inc. | 753018100 | $3K | 0.00 | 3,608 | EC | US |
| Aardvark Therapeutics, Inc. | 002942100 | $3K | 0.00 | 804 | EC | US |
| Gossamer Bio, Inc. | 38341P102 | $2K | 0.00 | 8,555 | EC | US |
| Cartesian Therapeutics, Inc. | 816212112 | $0 | 0.00 | 9,785 | OTHER | US |
| Third Harmonic Bio, Inc. | 88427A107 | $0 | 0.00 | 1,662 | EC | US |
| Unknown security | · | -$1.7M | -2.36 | 633 | DE | US |
Dividends 13 payments
| Ex-date | Amount / share |
|---|---|
| Sept. 23, 2026 | $0.0830 |
| March 25, 2026 | $0.0070 |
| Dec. 24, 2025 | $0.1350 |
| Sept. 24, 2025 | $0.1810 |
| June 25, 2025 | $0.1710 |
| March 26, 2025 | $0.1310 |
| Dec. 23, 2024 | $0.3960 |
| Sept. 25, 2024 | $0.1530 |
| June 26, 2024 | $0.2650 |
| March 20, 2024 | $0.0400 |
| Dec. 20, 2023 | $0.0380 |
| Dec. 22, 2022 | $0.0200 |
| Sept. 21, 2010 | $0.0110 |
Institutional owners (13F) 22 filers
Institutions that report holding this ETF in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| Institution | Value | % of tracked 13F | Shares | Type | As of |
|---|---|---|---|---|---|
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $785,973 | 21.94% | 7,802 | Shares | June 30, 2026 |
| Capital Investment Advisors, LLC | $599,013 | 16.72% | 5,946 | Shares | June 30, 2026 |
| Kaizen Financial Strategies | $535,554 | 14.95% | 5,315 | Shares | June 30, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $413,034 | 11.53% | 4,100 | Call option | June 30, 2026 |
| Palumbo Wealth Management LLC | $402,960 | 11.25% | 4,000 | Shares | June 30, 2026 |
| CITADEL ADVISORS LLC | $302,220 | 8.44% | 3,000 | Call option | June 30, 2026 |
| Jump Financial, LLC | $257,189 | 7.18% | 2,553 | Shares | June 30, 2026 |
| TOTH FINANCIAL ADVISORY CORP | $102,957 | 2.87% | 1,022 | Shares | June 30, 2026 |
| FRANKLIN RESOURCES INC | $70,115 | 1.96% | 696 | Shares | June 30, 2026 |
| PNC Financial Services Group, Inc. | $50,370 | 1.41% | 500 | Shares | June 30, 2026 |
| Ashton Thomas Private Wealth, LLC | $37,576 | 1.05% | 373 | Shares | June 30, 2026 |
| Truvestments Capital LLC | $12,593 | 0.35% | 125 | Shares | June 30, 2026 |
| Axiom Investment Management LLC | $5,037 | 0.14% | 50 | Shares | June 30, 2026 |
| Qube Research & Technologies Ltd | $4,936 | 0.14% | 49 | Shares | June 30, 2026 |
| SIMPLEX TRADING, LLC | $1,309 | 0.04% | 13 | Shares | June 30, 2026 |
| CHASE INVESTMENT COUNSEL CORP | $241 | 0.01% | 2,400 | Shares | June 30, 2026 |
| Rockefeller Capital Management L.P. | $201 | 0.01% | 2 | Shares | June 30, 2026 |
| MORGAN STANLEY | $131 | 0.00% | 1 | Shares | June 30, 2026 |
| UBS Group AG | $101 | 0.00% | 1 | Shares | June 30, 2026 |
| WELLS FARGO & COMPANY/MN | $65 | 0.00% | 1 | Shares | June 30, 2026 |
| Harel Insurance Investments & Financial Services Ltd. | $20 | 0.00% | 198 | Shares | June 30, 2026 |
| ROYAL BANK OF CANADA | $0 | 0.00% | 1 | Shares | June 30, 2026 |